"Phase I/II Evaluation of Candidate AIDS Vaccines."

According to an abstract submitted by the author to the 11th International Conference on AIDS, held July 7-12, 1996, in Vancouver, British Columbia, "Issue: Development of a preventive vaccine for AIDS. Project: The AIDS Vaccine Evaluation Group (AVEG) sponsored by NIAID consists of 6 University-based clinical testing sites, 2 central laboratories, a central data processing and analysis unit, and administrative support to select vaccine candidates, evaluate safety, and manage reagent and repository needs. Studies are focused on defining the safety and immunogenicity profiles of candidate vaccines to identify vaccination strategies that are sufficiently promising to be...

Want to see the full article?

• Purchase this article for only $3.00